Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > CMED 61% held by general public?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by value1on Nov 19, 2017 7:41pm
166 Views
Post# 26993351

RE:RE:RE:RE:CMED 61% held by general public?

RE:RE:RE:RE:CMED 61% held by general public?They dont even have a brand that sells at this point. They have no sales license. Who is their grower. You have none of those answers. They didnt even change the name and symbol for gods sake. Its ridiculous and strictly a way to try and fight off acb. What cmed shareholder would go for the newstrike resources deal. Toy have a beast in aurora. Traded 400 million shares in 5 days. I think a formal offer comes. Funds will be gobbling up cmed shares up to 21. It traded 2.5 mill between 15-21 so between that the 40 percent they have and whatever gets bought theyll get 66 percent. They could have bought emblem for the same price and at least got cultivation sale oils and production along with pharma that fits their strategy.  Trying to save their jobs by making a terrible deal. How is this good for the shareholder. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities